Metabolism meets immunity: The role of free fatty acid receptors in the immune system (Q26752828)

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

A Role for Gut Microbiota and the Metabolite-Sensing Receptor GPR43 in a Murine Model of Gout

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

G protein-coupled receptor 84, a microglia-associated protein expressed in neuroinflammatory conditions

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Acetate, propionate and butyrate in plasma: determination of the concentration and isotopic enrichment by gas chromatography/mass spectrometry with positive chemical ionization

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

A cluster of four novel human G protein-coupled receptor genes occurring in close proximity to CD22 gene on chromosome 19q13.1

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

An expressed sequence tag (EST) data mining strategy succeeding in the discovery of new G-protein coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Free fatty acid receptors and their role in regulation of energy metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

GPR120 (FFAR4) is preferentially expressed in pancreatic delta cells and regulates somatostatin secretion from murine islets of Langerhans

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Free fatty acid receptor 1 (FFA(1)R/GPR40) and its involvement in fatty-acid-stimulated insulin secretion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Experimental challenges to targeting poorly characterized GPCRs: uncovering the therapeutic potential for free fatty acid receptors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Mucosal biofilm communities in the human intestinal tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Arrestin pathways as drug targets.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Role of free fatty acid receptors in the regulation of energy metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Agonism with the omega-3 fatty acids alpha-linolenic acid and docosahexaenoic acid mediates phosphorylation of both the short and long isoforms of the human GPR120 receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Cloning, expression, and pharmacological characterization of the GPR120 free fatty acid receptor from cynomolgus monkey: comparison with human GPR120 splice variants

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Fishing Out a Sensor for Anti-inflammatory Oils

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Beta-arrestins as regulators of signal termination and transduction: How do they determine what to scaffold?

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Differential requirements of arrestin-3 and clathrin for ligand-dependent and -independent internalization of human G protein-coupled receptor 40.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Omega 3 fatty acids and GPR120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

SnapShot: Immunometabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Obesity and Cancer: The Oil that Feeds the Flame

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Pathways and functions of gut microbiota metabolism impacting host physiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Inflammatory changes in adipose tissue enhance expression of GPR84, a medium-chain fatty acid receptor: TNFα enhances GPR84 expression in adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

The G-protein coupled receptor, GPR84 regulates IL-4 production by T lymphocytes in response to CD3 crosslinking

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

The immune system as a sensor of the metabolic state

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Diet, metabolites, and "western-lifestyle" inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Monitoring ligand-mediated internalization of G protein-coupled receptor as a novel pharmacological approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

GPR40 (FFAR1) - Combined Gs and Gq signaling in vitro is associated with robust incretin secretagogue action ex vivo and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

The structural basis of arrestin-mediated regulation of G-protein-coupled receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Pharmacology and therapeutics of omega-3 polyunsaturated fatty acids in chronic inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Free fatty acid receptors act as nutrient sensors to regulate energy homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

The fatty acid receptor FFA1/GPR40 a decade later: how much do we know?

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

β-Arrestin-mediated receptor trafficking and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

G-protein-coupled receptors for free fatty acids: nutritional and therapeutic targets.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Nutrient sensing and signalling by the gut.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

n-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Complex Pharmacology of Free Fatty Acid Receptors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Discovery and optimization of an azetidine chemical series as a free fatty acid receptor 2 (FFA2) antagonist: from hit to clinic

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Discovery and Optimization of Potent GPR40 Full Agonists Containing Tricyclic Spirocycles

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

A central role for JNK in obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Richness of human gut microbiome correlates with metabolic markers

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Diet, gut microbiota and immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

IKK-beta links inflammation to obesity-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

The cellular and signaling networks linking the immune system and metabolism in disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Eosinophils in the spotlight: Finding the link between obesity and asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Teaching old receptors new tricks: biasing seven-transmembrane receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Regulation of metabolism by the innate immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Monocyte and macrophage heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Identification of G-protein-coupled receptor 120 as a tumor-promoting receptor that induces angiogenesis and migration in human colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Omega-3 fatty acids reduce obesity-induced tumor progression independent of GPR120 in a mouse model of postmenopausal breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Human GPR42 is a transcribed multisite variant that exhibits copy number polymorphism and is functional when heterologously expressed.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

The G-protein-coupled receptor GPR40 directly mediates long-chain fatty acid-induced secretion of cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41)

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Alteration of the glucagon axis in GPR120 (FFAR4) knockout mice: a role for GPR120 in glucagon secretion

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Concomitant action of structural elements and receptor phosphorylation determines arrestin-3 interaction with the free fatty acid receptor FFA4

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Non-equivalence of Key Positively Charged Residues of the Free Fatty Acid 2 Receptor in the Recognition and Function of Agonist Versus Antagonist Ligands.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Medium-chain fatty acids as ligands for orphan G protein-coupled receptor GPR84

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

G protein-coupled receptors in human fat taste perception

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Drugs or diet?--Developing novel therapeutic strategies targeting the free fatty acid family of GPCRs

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Microbial influences on epithelial integrity and immune function as a basis for inflammatory diseases.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Differential signaling by splice variants of the human free fatty acid receptor GPR120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Distinct Phosphorylation Clusters Determine the Signaling Outcome of Free Fatty Acid Receptor 4/G Protein-Coupled Receptor 120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

The Pharmacology and Function of Receptors for Short-Chain Fatty Acids.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: pharmacology and pathophysiological functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

The NLRP3 inflammasome: a sensor for metabolic danger?

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Short chain fatty acids in human large intestine, portal, hepatic and venous blood

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Contribution of the low-frequency, loss-of-function p.R270H mutation in FFAR4 (GPR120) to increased fasting plasma glucose levels

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Alternative activation of macrophages: an immunologic functional perspective

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Anti-inflammatory and proresolving lipid mediators

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Molecular mechanism of β-arrestin-biased agonism at seven-transmembrane receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Free fatty acid (FFA) and hydroxy carboxylic acid (HCA) receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Macrophages, inflammation, and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Immunomodulation by polyunsaturated fatty acids: mechanisms and effects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

TLR4 links innate immunity and fatty acid-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Expression analysis of G Protein-Coupled Receptors in mouse macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Arrestins: ubiquitous regulators of cellular signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Duodenal enteroendocrine I-cells contain mRNA transcripts encoding key endocannabinoid and fatty acid receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

The beneficial effects of n-3 polyunsaturated fatty acids on diet induced obesity and impaired glucose control do not require Gpr120.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Functional analysis of free fatty acid receptor GPR120 in human eosinophils: implications in metabolic homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

The role of G-protein receptor 84 in experimental neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

The therapeutic potential of allosteric ligands for free fatty acid sensitive GPCRs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Increased Inflammatory Properties of Adipose Tissue Macrophages Recruited During Diet-Induced Obesity

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Characterization of distinct subpopulations of hepatic macrophages in HFD/obese mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Selective FFA2 Agonism Appears to Act via Intestinal PYY to Reduce Transit and Food Intake but Does Not Improve Glucose Tolerance in Mouse Models

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Tumor necrosis factor alpha: a key component of the obesity-diabetes link

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Low affinity GPCRs for metabolic intermediates: challenges for pharmacologists.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

The SCFA Receptor GPR43 and Energy Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Eosinophilic inflammation in allergic asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Mechanisms of action of (n-3) fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

Fatty acids as biocompounds: their role in human metabolism, health and disease: a review. part 2: fatty acid physiological roles and applications in human health and disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2016.03.017

7 January 2021

10.1016/J.BCP.2016.03.017

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

27002183

1 reference

Consolidated OpenCitations Corpus – April 2017